glp-1 guidelines for weight loss is only severely obese people. The clinical say otherwise. You may qualify for GLP-1 medication if you have a BMI of 30 or higher, OR a BMI of 27 GLP-1-directed NMDA receptor antagonism for

This approach prioritizes metabolic health, muscle preservation, and hormonal balance rather than rapid weight loss alone

In addition to multiple late-breaking clinical trial sessions featuring newly released data on the efficacy of this class of drugs, alone and in combination with other agents, the 2026 Scientific Sessions highlighted the latest findings and guidance on using GLP-1 RA therapies in the Monday, June 8, symposium, GLP-1 Receptor Agonists: Whats New in 2026

Work with your provider to develop a tapering plan that minimizes withdrawal effects and weight regain

Basal levels of insulin and glucagon were similar between somatostatin knockout mice and controls